Jellyfish-inspired device could aid drug delivery
Researchers have taken inspiration from jellyfish to create a small device that could be utilised for drug delivery.
List view / Grid view
Researchers have taken inspiration from jellyfish to create a small device that could be utilised for drug delivery.
Two pharmaceutical companies have partnered to develop a slow-release drug to treat patients with HIV.
A research group has designed a pills-on-a-coil system to administer drugs without having to take pills.
A study has shown that crystallising drugs removes localised immune reaction, allowing long-term release of drugs from medical devices.
AstraZeneca today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to add a self-administration option for Fasenra (benralizumab) and a new delivery method as a pre-filled, single-use auto-injector (the Fasenra pen) to the medicine’s product information in the European…
Nature can offer inspiration for the synthesis of more effective drug delivery platforms. In this article, Marc Baiget Francesch discusses the potential of capsosomes as a novel, biocompatible, drug delivery system.
A team at the Technical University of Munich have made it possible for nano particles to be released in sequence with the use of artificial DNA.
Researchers have developed a new drug delivery system that can be remotely controlled to administer patients with medication.
Researchers have developed a method of creating stable nanoemulsions which could be used in new drug delivery processes.
Whether by ignorance of the latest best practices, or willful disregard for patient safety, the results of careless practice can often be fatal. The articles in this in-depth focus highlight how regulatory bodies are taking action to raise the industry’s game.
This in-depth focus looks into industrial workflow processes and also how nature can provide inspiration for drug delivery.
The increasing complexity of formulations and active biological products raises new challenges for pre-filled syringe development. James Mellman, Device Manager at Novartis, speaks to Nikki Withers about the challenges of selecting the right primary packaging for injectable formulations and how he has learnt to expect the unexpected.
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.
JRS Pharma present VIVAPUR MCG and outline the benefits of its formulation for application in nasal sprays.